SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC. 20549

FORM  11-K

ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF 
THE SECURITIES EXCHANGE ACT OF 1934


For the fiscal year ended December 31, 1993

Registration number 2-56218


	A. Full title of the plan:

ORAL-B LABORATORIES SAVINGS PLAN
One Lagoon Drive
Redwood City, CA 94065


	B. Name of the issuer of the securities held 
pursuant to the plan and the address of its principal 
executive office:

The Gillette Company
Prudential Tower Building
Boston, MA 02199



Financial Statements of the Oral-B Laboratories 
Savings Plan


	In lieu of the requirements of Items 1 through 3, 
the Oral-B Laboratories Savings Plan is filing financial 
statements and schedules prepared in accordance with 
ERISA. Pursuant to Rule 311 of Regulation S-T, the 
financial statements and schedules are being filed in 
paper format under cover of Form SE and the following 
legend will appear on the transmittal letter accompanying  
the paper format documents:

THIS PAPER FORMAT DOCUMENT IS BEING 
SUBMITTED IN ACCORDANCE WITH RULE 311 OF 
REGULATION S-T.


Exhibits 

	24	Consent of KPMG Peat Marwick to the 	
		incorporation by reference of  the Plan's 
		financial statements into Registration 	
		Statement  No. 2-93230 on Form S-8 under 
		the Securities Act of 1933.



SIGNATURES 

	Pursuant to the requirements of the Securities 
Exchange Act of 1934, the Savings Plan Committee has 
duly caused this annual report to be signed on its behalf 
by the undersigned hereunto duly authorized.


Oral-B Laboratories Savings Plan

By ROBERT E. DICENSO
Robert E. DiCenso
Senior Vice President-Administration
The Gillette Company
Date:	June 27, 1994